(¿Â¶óÀÎ)Á¦9ȸ ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ Çмú´ëȸ ¹× ¿¬¼ö°Á : 2021-09-26±³À°ÀÏÀÚ : 2021-09-26
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ)Á¦9ȸ ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ Çмú´ëȸ ¹× ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê¿ï»ê°æ³²Áöȸ
´ã´çÀÚ : ¼Û¿¬Á¤
¿¬¶ôó : 070-4888-0731
À̸ÞÀÏ :
pukendo@naver.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 10 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í °³¿øÀÇ, ºÀÁ÷ÀÇ 2¸¸¿ø / Àü°øÀÇ, °øº¸ÀÇ, ±ºÀÇ°ü, ¿µ¾ç»ç, °£È£»ç, »çȸº¹Áö»ç 1¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 09:00~09:30 Updated Guideline in Heart Failure Treatment Ȳ¼®Àç(°æ»ó´ëÇб³º´¿ø ½ÉÀå³»°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 09:30~10:00 ARNI vs ACEI or ARB as a heart failure treatment ÀÓ°æÈñ(µ¿¾Æ´ëÇб³º´¿ø ½ÉÀå³»°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 10:00~10:30 Ivabradine in heart failure with or without diabetes ±èº¸Çö(ºÎ»ê´ëÇб³º´¿ø ³»ºÐºñ³»°ú)
Åä·Ð 09-26
http://pukendo.dothome.co.kr/ 10:30~10:40 Q&A ()
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 09:00~09:30 Endoscopic surgery for pituitary tumor ¼º¼ø±â(¾ç»êºÎ»ê´ëÇб³º´¿ø ½Å°æ¿Ü°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 09:30~10:00 Post-operative management for pituitary tumor Áø»ó¿í(°æÈñ´ëÇб³º´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 10:00~10:30 Medical treatment of recurrent cushing syndrome ±¸Ã¶·æ(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø ³»ºÐºñ³»°ú)
Åä·Ð 09-26
http://pukendo.dothome.co.kr/ 10:30~10:40 Q&A ()
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 10:50~11:20 Altered sympathetic nervous system in the diabetic heart ±èºÀÁØ(°í½Å´ëÇб³ º¹À½º´¿ø ½ÉÀå³»°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 11:20~11:50 Progression of chronic kidney disease in type 2 diabetes ¹®ÁÖ¿µ(°µ¿°æÈñ´ëº´¿ø ½ÅÀå³»°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 11:50~12:20 SGLT2i as a treatment option in cardiorenal syndrome ±èųâ(ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø ³»ºÐºñ³»°ú)
Åä·Ð 09-26
http://pukendo.dothome.co.kr/ 12:20~12:30 Q&A ()
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 10:50~11:20 Pregnancy in patients with congenital adrenal hyperplasia ±èÁ¤Èñ(¼¿ï´ëÇб³º´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 11:20~11:50 Medical treatment for primary hyperaldosteronism ¹ÚÁ¤È¯(ÇѾç´ëÇб³º´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 11:50~12:20 Adreno cortical sparing adrenalectomy in adrenal tumor ÃÖÁ¤¹ü(ºÎ»ê´ëÇб³º´¿ø ¿Ü°ú)
Åä·Ð 09-26
http://pukendo.dothome.co.kr/ 12:20~12:30 Q&A ()
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 13:30~13:50 2021 ´ç´¢º´ Áø·áÁöħ ¾÷µ¥ÀÌÆ® °¼±¹Ì(ÀÎÁ¦´ëÇб³ ºÎ»ê¹éº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 13:50~14:10 ´ç´¢º´ ȯÀÚÀÇ ½ÉÇ÷°ü À§ÇèÀÎÀÚ °ü¸® ¹éÁ¾ÇÏ(â¿ø°æ»ó´ëÇб³º´¿ø ³»ºÐºñ³»°ú)
Åä·Ð 09-26
http://pukendo.dothome.co.kr/ 14:10~14:20 Q&A ()
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 14:20~14:40 ÀӽŰú °©»ó¼±±â´ÉÀúÇÏÁõ ±èÇýÀÎ(â¿ø»ï¼ºº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 14:40~15:00 ÀӽŰú °©»ó¼±±â´ÉÇ×ÁøÁõ ÀÌÇý¿ø(µ¿³²±Ç¿øÀڷº´¿ø ³»ºÐºñ³»°ú)
Åä·Ð 09-26
http://pukendo.dothome.co.kr/ 15:00~15:10 Q&A ()
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 15:20~15:40 ³²¼ºÈ£¸£¸ó Ä¡·áÀÇ ÀûÀÀÁõ°ú ½ÇÁ¦ ó¹æ ¹ÚÇöÁØ(ºÎ»ê´ëÇб³º´¿ø ºñ´¢±â°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 15:40~16:00 ¿©¼ºÈ£¸£¸ó Ä¡·áÀÇ ÀûÀÀÁõ°ú ½ÇÁ¦ ó¹æ ÁÖÁ¾±æ(ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú)
Åä·Ð 09-26
http://pukendo.dothome.co.kr/ 16:00~16:10 Q&A ()
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 16:10~16:30 °ñÇü¼ºÃËÁøÁ¦ ³ªµµ ¾µ ¼ö ÀÖÀ»±î? ±èÀºÈñ(ºÎ»ê´ëÇб³º´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 09-26
http://pukendo.dothome.co.kr/ 16:30~16:50 °ñ´Ù°øÁõ Ä¡·á Áß Ä¡°úÄ¡·á ¾î¶»°Ô ÇÒ±î¿ä? ÀüÀ±°æ(ºÎ»ê´ëÇб³º´¿ø ³»ºÐºñ³»°ú)
Åä·Ð 09-26 16:50~17:00 Q&A ()